Literature DB >> 11768581

The clinically variable R40H mutant ornithine carbamoyltransferase shows cytosolic degradation of the precursor protein in CHO cells.

M Mavinakere1, H Morizono, D Shi, N M Allewell, M Tuchman.   

Abstract

Ornithine carbamoyltransferase (OCT) deficiency is now frequently found in adults with hyperammonaemia affected by mutations that cause partial deficiency of this urea cycle enzyme. One of these mutations (R40H) has occurred in several families and has been found also in asymptomatic relatives. To better understand the phenotypic heterogeneity of this recurrent mutation, we investigated the biological properties of the mutant protein. Using 35S labelling, the import and processing of the R40H mutant OCT protein was investigated in intact CHO cells and in isolated rat liver mitochondria and compared to the wild type and R141Q mutant that causes complete enzyme deficiency. The R40H OCT protein seems to be imported and processed by the mitochondria in a manner similar to that of wild type. However, it is consistently degraded to a smaller fragment in the intact cells, unlike the wild type and R141Q mutant. The mature form of the enzyme is not susceptible to degradation. These data, obtained in CHO cells, suggest that deficiency in OCT enzymatic function conferred by the R40H mutation is likely caused by enhanced degradation of the preprotein in the cytosol. We propose therefore that variation in the rate of OCT turnover is responsible for the heterogeneity of the clinical phenotype in these patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11768581     DOI: 10.1023/a:1012726207870

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  11 in total

1.  Expression of wild-type and mutant human ornithine transcarbamylase genes in Chinese hamster ovary cells and lack of dominant negative effect of R141Q and R40H mutants.

Authors:  L Augustin; M Mavinakere; H Morizono; M Tuchman
Journal:  Pediatr Res       Date:  2000-12       Impact factor: 3.756

2.  Substrate-induced conformational change in a trimeric ornithine transcarbamoylase.

Authors:  Y Ha; M T McCann; M Tuchman; N M Allewell
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

3.  The R40H mutation in a late onset type of human ornithine transcarbamylase deficiency in male patients.

Authors:  A Nishiyori; M Yoshino; H Kato; T Matsuura; R Hoshide; I Matsuda; T Kuno; S Miyazaki; S Hirose; R Kuromaru; M Mori
Journal:  Hum Genet       Date:  1997-02       Impact factor: 4.132

4.  Mitochondrial intermediate peptidase.

Authors:  G Isaya; F Kalousek
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

5.  'Late onset' ornithine transcarbamylase deficiency: function of three purified recombinant mutant enzymes.

Authors:  H Morizono; C D Listrom; B S Rajagopal; M Aoyagi; M T McCann; N M Allewell; M Tuchman
Journal:  Hum Mol Genet       Date:  1997-06       Impact factor: 6.150

6.  Phenotypic variability in male patients carrying the mutant ornithine transcarbamylase (OTC) allele, Arg40His, ranging from a child with an unfavourable prognosis to an asymptomatic older adult.

Authors:  I Matsuda; T Matsuura; A Nishiyori; S Komaki; R Hoshide; T Matsumoto; M Funakoshi; K Kiwaki; F Endo; A Hata; M Shimadzu; M Yoshino
Journal:  J Med Genet       Date:  1996-08       Impact factor: 6.318

7.  Missense mutations in codon 225 of ornithine transcarbamylase (OTC) result in decreased amounts of OTC protein: a hypothesis on the molecular mechanism of the OTC deficiency.

Authors:  M A García-Pérez; C Climent; P Briones; M A Vilaseca; M Rodés; V Rubio
Journal:  J Inherit Metab Dis       Date:  1997-11       Impact factor: 4.982

8.  The biochemical and molecular spectrum of ornithine transcarbamylase deficiency.

Authors:  M Tuchman; H Morizono; B S Rajagopal; R J Plante; N M Allewell
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

9.  Targeting of pre-ornithine transcarbamylase to mitochondria: definition of critical regions and residues in the leader peptide.

Authors:  A L Horwich; F Kalousek; W A Fenton; R A Pollock; L E Rosenberg
Journal:  Cell       Date:  1986-02-14       Impact factor: 41.582

10.  Prolonged metabolic correction in adult ornithine transcarbamylase-deficient mice with adenoviral vectors.

Authors:  X Ye; M B Robinson; M L Batshaw; E E Furth; I Smith; J M Wilson
Journal:  J Biol Chem       Date:  1996-02-16       Impact factor: 5.157

View more
  3 in total

Review 1.  Genotype-Phenotype Correlations in Ornithine Transcarbamylase Deficiency: A Mutation Update.

Authors:  Ljubica Caldovic; Iman Abdikarim; Sahas Narain; Mendel Tuchman; Hiroki Morizono
Journal:  J Genet Genomics       Date:  2015-05-19       Impact factor: 4.275

2.  Urea cycle disorders in Spain: an observational, cross-sectional and multicentric study of 104 cases.

Authors:  Elena Martín-Hernández; Luis Aldámiz-Echevarría; Esperanza Castejón-Ponce; Consuelo Pedrón-Giner; María Luz Couce; Juliana Serrano-Nieto; Guillem Pintos-Morell; Amaya Bélanger-Quintana; Mercedes Martínez-Pardo; María Teresa García-Silva; Pilar Quijada-Fraile; Isidro Vitoria-Miñana; Jaime Dalmau; Rosa A Lama-More; María Amor Bueno-Delgado; Mirella Del Toro-Riera; Inmaculada García-Jiménez; Concepción Sierra-Córcoles; Mónica Ruiz-Pons; Luis J Peña-Quintana; Inmaculada Vives-Piñera; Ana Moráis; Elena Balmaseda-Serrano; Silvia Meavilla; Pablo Sanjurjo-Crespo; Celia Pérez-Cerdá
Journal:  Orphanet J Rare Dis       Date:  2014-11-30       Impact factor: 4.123

3.  Common polymorphic OTC variants can act as genetic modifiers of enzymatic activity.

Authors:  Mónica Lopes-Marques; Ana Rita Pacheco; Maria João Peixoto; Ana Rita Cardoso; Catarina Serrano; António Amorim; Maria João Prata; David N Cooper; Luísa Azevedo
Journal:  Hum Mutat       Date:  2021-06-03       Impact factor: 4.878

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.